Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Day

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Neuromuscular Disorders : NMD|August 20, 2011
2010 Marigold therapeutic strategies for myotonic dystrophyKarla Blonsky, Darren Monckton, Bé Wieringa, et al.
Stem Cell Research|August 7, 2025
Generation of two induced pluripotent stem cell lines from patients with Facioscapulohumeral muscular dystrophyRavichandra Venkateshappa, Francesca Vacante, Lingyun Xu, et al.
Neuromuscular Disorders : NMD|December 21, 2010
White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging studyJeffrey R Wozniak, Bryon A Mueller, Erin E Ward, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 11, 2021
Toward Developing Robust Myotonic Dystrophy Brain Biomarkers using White Matter Tract Profiles Sub-Band Energy and A Framework of Ensemble Predictive LearningTahereh Kamali, Dana Parker, John W Day, et al.
BMC Pediatrics|November 4, 2022
Advances and limitations for the treatment of spinal muscular atrophyJohn W Day, Kelly Howell, Amy Place, et al.
Journal of the Neurological Sciences|April 29, 2014
Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1Jeffrey R Wozniak, Bryon A Mueller, Kelvin O Lim, et al.
Human Molecular Genetics|April 21, 2006
DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expressionJamie M Margolis, Benedikt G Schoser, Melinda L Moseley, et al.
Neoreviews|June 30, 2022
Spinal Muscular Atrophy Type 1: Fetal Diagnosis, Prenatal Coordination, and Postnatal Management in the Era of Novel TherapiesRitu Chitkara, Valerie Chock, Alexis Davis, et al.
The Journal of Pediatrics|July 1, 2021
Advances in the Therapy of Spinal Muscular AtrophyJenna Klotz, Carolina Tesi Rocha, Sally Dunaway Young, et al.
Brain Research|May 1, 2014
Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutationsAlya R Raphael, Julien Couthouis, Sarada Sakamuri, et al.
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Neuromuscular Disorders : NMD|August 20, 2011
2010 Marigold therapeutic strategies for myotonic dystrophyKarla Blonsky, Darren Monckton, Bé Wieringa, et al.
Stem Cell Research|August 7, 2025
Generation of two induced pluripotent stem cell lines from patients with Facioscapulohumeral muscular dystrophyRavichandra Venkateshappa, Francesca Vacante, Lingyun Xu, et al.
Neuromuscular Disorders : NMD|December 21, 2010
White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging studyJeffrey R Wozniak, Bryon A Mueller, Erin E Ward, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 11, 2021
Toward Developing Robust Myotonic Dystrophy Brain Biomarkers using White Matter Tract Profiles Sub-Band Energy and A Framework of Ensemble Predictive LearningTahereh Kamali, Dana Parker, John W Day, et al.
BMC Pediatrics|November 4, 2022
Advances and limitations for the treatment of spinal muscular atrophyJohn W Day, Kelly Howell, Amy Place, et al.
Journal of the Neurological Sciences|April 29, 2014
Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1Jeffrey R Wozniak, Bryon A Mueller, Kelvin O Lim, et al.
Human Molecular Genetics|April 21, 2006
DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expressionJamie M Margolis, Benedikt G Schoser, Melinda L Moseley, et al.
Neoreviews|June 30, 2022
Spinal Muscular Atrophy Type 1: Fetal Diagnosis, Prenatal Coordination, and Postnatal Management in the Era of Novel TherapiesRitu Chitkara, Valerie Chock, Alexis Davis, et al.
The Journal of Pediatrics|July 1, 2021
Advances in the Therapy of Spinal Muscular AtrophyJenna Klotz, Carolina Tesi Rocha, Sally Dunaway Young, et al.
Brain Research|May 1, 2014
Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutationsAlya R Raphael, Julien Couthouis, Sarada Sakamuri, et al.
Pageof 16